Switching Between Antibiotics Among Danish Children 0-4 Years of Age: A Nationwide Drug Utilization Study

The Pediatric Infectious Disease Journal
Mette ReilevAnton Pottegård

Abstract

In Denmark, the use of amoxicillin is widespread among children, despite phenoxymethylpenicillin being recommended as first-line therapy. The reason for this apparent discrepancy is not fully understood. We aimed at evaluating prescribing patterns of antibiotics among Danish children 0-4 years of age, with emphasis on incidence of treatment episodes, choice of initial antibiotic treatment and switching patterns between different types of antibiotics. We identified all children ≤4 years of age who filled a prescription of antibiotics from 2000 to 2015 according to the nationwide Danish National Prescription Registry. We estimated the incidence rate of episodes treated with antibiotics and the choice of initial antibiotic treatment over time. Further, we assessed the cumulative risk of switching within 0-3 days after initiating therapy. We identified 3,481,684 antibiotic treatment episodes issued to 0- to 4-year-olds from 2000 to 2015. The incidence rate was stable until 2011 both among children 0-1 years of age (approximately 880/1000) and among children 2-4 years of age (approximately 610/1000), after which it dropped. Phenoxymethylpenicillin and, increasingly, amoxicillin were most frequently used as initial treatments (39% vs...Continue Reading

References

Apr 1, 1997·Clinical Pediatrics·R W SteeleM P Thomas
Jun 17, 2009·European Journal of Clinical Pharmacology·Antonio Clavenna, Maurizio Bonati
Dec 22, 2010·The Journal of Antimicrobial Chemotherapy·Verena Schneider-LindnerSamy Suissa
Sep 8, 2011·Scandinavian Journal of Public Health·Lau Caspar ThygesenHenrik Brønnum-Hansen
Nov 18, 2011·Archives of Disease in Childhood·Dave BaguleySaul N Faust
Feb 12, 2013·European Journal of Pediatrics·Jakob Holstiege, Edeltraut Garbe
Feb 4, 2014·Pediatrics·Louise Elaine VazJonathan A Finkelstein
Apr 24, 2014·European Journal of Clinical Pharmacology·Anton PottegårdJesper Hallas
Jul 19, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Zitta Barrella HarboePalle Valentiner-Branth
Aug 22, 2014·The Pediatric Infectious Disease Journal·Anton PottegårdPer Damkier
Aug 30, 2014·Basic & Clinical Pharmacology & Toxicology·Sara MaloMaría-José Rabanaque
Mar 8, 2016·The Journal of Antimicrobial Chemotherapy·Verica IvanovskaLiset van Dijk
Apr 24, 2016·The Journal of Antimicrobial Chemotherapy·Rune AabenhusLars Bjerrum
Nov 29, 2016·International Journal of Epidemiology·Morten SchmidtSøren Friis
Dec 26, 2016·The Journal of Pediatrics·Ilan YoungsterSeoyoung C Kim

❮ Previous
Next ❯

Citations

Jun 10, 2018·Acta Ophthalmologica·Jasmine AnderssonAnton Pottegård
Jan 27, 2019·BMC Infectious Diseases·Loek A W de JongUNKNOWN SWAB’s Working Group on Surveillance of Antimicrobial Use

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.